To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/1822/85451 |
Resumo: | Background The work on the ESGB guidelines for diagnosis and treatment of biofilm infections began in 2012 and the result was published in 2014. The guidelines have been and still are frequently cited in the literature proving its usefulness for people working with biofilm infections. At the ESGB Biofilm conference in Mallorca 2022 (Eurobiofilms2022) the board of the ESGB decided to evaluate the 2014-guidelines and relevant publications since 2014 based on a lecture given at the Eurobiofilms2022. Guideline methods The Delphi method for working on production of guidelines and the current ESCMID rules for guidelines are presented. The criteria for evaluation of relevant literature are very strict and especially for treatment, most clinicians and regulatory authorities require convincing results from Level I (randomized controlled trials) publications to justify changes of treatments. The relevant new biofilm literature and the relevant biofilm presentations from the Eurobiofilms meetings and ECCMID conferences was used for evaluating the contemporary relevance of the ESGB 2014 guidelines. Diagnosis of biofilm infections Several infectious diseases have been recognized as biofilm infections since 2014, but the diagnostic methods and therapeutic strategies are still the same as recommended in the 2014 ESGB guidelines which are summarized in this opinion paper. Treatment of biofilm infections Some promising new in vitro and in vivo (animal experiments) observations and reports for therapy of biofilm infections are mentioned, but they still await clinical trials. Conclusion The interim opinion at the present time (2022) is therefore, that the guidelines do not need revision now, but there is a need for survey articles discussing new methods of diagnosis and treatment of biofilm infections in order - hopefully to give inspiration to conduct clinical trials which may lead to progress in diagnosis and treatment of patients with biofilm infections. |
id |
RCAP_ab61181262de9d00e03d47e398908ff0 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/85451 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB boardBackground The work on the ESGB guidelines for diagnosis and treatment of biofilm infections began in 2012 and the result was published in 2014. The guidelines have been and still are frequently cited in the literature proving its usefulness for people working with biofilm infections. At the ESGB Biofilm conference in Mallorca 2022 (Eurobiofilms2022) the board of the ESGB decided to evaluate the 2014-guidelines and relevant publications since 2014 based on a lecture given at the Eurobiofilms2022. Guideline methods The Delphi method for working on production of guidelines and the current ESCMID rules for guidelines are presented. The criteria for evaluation of relevant literature are very strict and especially for treatment, most clinicians and regulatory authorities require convincing results from Level I (randomized controlled trials) publications to justify changes of treatments. The relevant new biofilm literature and the relevant biofilm presentations from the Eurobiofilms meetings and ECCMID conferences was used for evaluating the contemporary relevance of the ESGB 2014 guidelines. Diagnosis of biofilm infections Several infectious diseases have been recognized as biofilm infections since 2014, but the diagnostic methods and therapeutic strategies are still the same as recommended in the 2014 ESGB guidelines which are summarized in this opinion paper. Treatment of biofilm infections Some promising new in vitro and in vivo (animal experiments) observations and reports for therapy of biofilm infections are mentioned, but they still await clinical trials. Conclusion The interim opinion at the present time (2022) is therefore, that the guidelines do not need revision now, but there is a need for survey articles discussing new methods of diagnosis and treatment of biofilm infections in order - hopefully to give inspiration to conduct clinical trials which may lead to progress in diagnosis and treatment of patients with biofilm infections.(undefined)info:eu-repo/semantics/publishedVersionElsevierUniversidade do MinhoHøiby, N.Moser, C.Oliver, A.Williams, C.Ramage, G.Borghi, E.Azeredo, JoanaMacia, M. D.2023-12-152023-12-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/85451engHøiby, N.; Moser, C.; Oliver, A.; Williams, C.; Ramage, G.; Borghi, E.; Azeredo, Joana; Macia, M. D., To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board. Biofilm, 6(100135), 20232590-207510.1016/j.bioflm.2023.100135100135https://www.sciencedirect.com/science/article/pii/S2590207523000321info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-12T01:17:32Zoai:repositorium.sdum.uminho.pt:1822/85451Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:04:02.921454Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
title |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
spellingShingle |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board Høiby, N. |
title_short |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
title_full |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
title_fullStr |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
title_full_unstemmed |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
title_sort |
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board |
author |
Høiby, N. |
author_facet |
Høiby, N. Moser, C. Oliver, A. Williams, C. Ramage, G. Borghi, E. Azeredo, Joana Macia, M. D. |
author_role |
author |
author2 |
Moser, C. Oliver, A. Williams, C. Ramage, G. Borghi, E. Azeredo, Joana Macia, M. D. |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Høiby, N. Moser, C. Oliver, A. Williams, C. Ramage, G. Borghi, E. Azeredo, Joana Macia, M. D. |
description |
Background The work on the ESGB guidelines for diagnosis and treatment of biofilm infections began in 2012 and the result was published in 2014. The guidelines have been and still are frequently cited in the literature proving its usefulness for people working with biofilm infections. At the ESGB Biofilm conference in Mallorca 2022 (Eurobiofilms2022) the board of the ESGB decided to evaluate the 2014-guidelines and relevant publications since 2014 based on a lecture given at the Eurobiofilms2022. Guideline methods The Delphi method for working on production of guidelines and the current ESCMID rules for guidelines are presented. The criteria for evaluation of relevant literature are very strict and especially for treatment, most clinicians and regulatory authorities require convincing results from Level I (randomized controlled trials) publications to justify changes of treatments. The relevant new biofilm literature and the relevant biofilm presentations from the Eurobiofilms meetings and ECCMID conferences was used for evaluating the contemporary relevance of the ESGB 2014 guidelines. Diagnosis of biofilm infections Several infectious diseases have been recognized as biofilm infections since 2014, but the diagnostic methods and therapeutic strategies are still the same as recommended in the 2014 ESGB guidelines which are summarized in this opinion paper. Treatment of biofilm infections Some promising new in vitro and in vivo (animal experiments) observations and reports for therapy of biofilm infections are mentioned, but they still await clinical trials. Conclusion The interim opinion at the present time (2022) is therefore, that the guidelines do not need revision now, but there is a need for survey articles discussing new methods of diagnosis and treatment of biofilm infections in order - hopefully to give inspiration to conduct clinical trials which may lead to progress in diagnosis and treatment of patients with biofilm infections. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-15 2023-12-15T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1822/85451 |
url |
https://hdl.handle.net/1822/85451 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Høiby, N.; Moser, C.; Oliver, A.; Williams, C.; Ramage, G.; Borghi, E.; Azeredo, Joana; Macia, M. D., To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections That is the question! The opinion of the ESGB board. Biofilm, 6(100135), 2023 2590-2075 10.1016/j.bioflm.2023.100135 100135 https://www.sciencedirect.com/science/article/pii/S2590207523000321 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132448923058176 |